Lung Cancer Trial, Recruiting (NCT05902559)

Lung Cancer Trial, Recruiting NCT05902559 Sponsor: University College, London Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05902559 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have attended one or more appointments as part of the NCL NHS Targeted Lung Health Check (TLHC) programme
You are between 55 and 74 years old (up to but not including your 75th birthday)
You are able to understand what the trial involves and can sign a written consent form

Who may not be able to join:

You do not wish to take part in the ALPINE trial
You are unable to understand what the trial involves or cannot sign a written consent form
A clinician involved in your care has decided that you are not suitable to take part in this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05902559

Sponsor: University College, London

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT05902559

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have attended one or more appointments as part of the NCL NHS Targeted Lung Health Check (TLHC) programme
You are between 55 and 74 years old (up to but not including your 75th birthday)
You are able to understand what the trial involves and can sign a written consent form

Who may not be able to join:

You do not wish to take part in the ALPINE trial
You are unable to understand what the trial involves or cannot sign a written consent form
A clinician involved in your care has decided that you are not suitable to take part in this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University College, London

Registry

ClinicalTrials.gov

Start date

1 August 2023

Est. completion

20 November 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

To identify novel molecular, immune and clinical biomarkers to improve the sensitivity and specificity of lung cancer screening beyond what is achieved with conventional risk prediction models and low-dose CT scanning.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov